A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial

BACKGROUND: Azithromycin is an orally active synthetic macrolide antibiotic with a wide range of anti-bacterial, anti-inflammatory and antiviral properties. It is a safe, inexpensive, generic licenced drug available worldwide and manufactured to scale and is a potential candidate therapy for pandemi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Hinks, Timothy S. C., Barber, Vicki S., Black, Joanna, Dutton, Susan J., Jabeen, Maisha, Melhorn, James, Rahman, Najib M, Richards, Duncan, Lasserson, Daniel, Pavord, Ian D., Bafadhel, Mona
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429453/
https://ncbi.nlm.nih.gov/pubmed/32807209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04593-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars